Drugs / PT-MSCs
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06996392 | May 2025 → Dec 2026 expected | liver disorder | Third Affiliated Hospital, Sun Yat-Sen University | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PT-MSCs | “this bioreactor is uniquely filled with immortalized mesenchymal stem cells (PT-MSCs) optimized for blood purification” NCT06996392 ↗ |
| Modality | Cell therapy | “immortalized mesenchymal stem cells (PT-MSCs)” NCT06996392 ↗ |